GLYCOL DIACETATE
General Information
Mainterm | GLYCOL DIACETATE |
CAS Reg.No.(or other ID) | 111-55-7 |
Regnum |
175.105 |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 8121 |
IUPAC Name | 2-acetyloxyethyl acetate |
InChI | InChI=1S/C6H10O4/c1-5(7)9-3-4-10-6(2)8/h3-4H2,1-2H3 |
InChI Key | JTXMVXSTHSMVQF-UHFFFAOYSA-N |
Canonical SMILES | CC(=O)OCCOC(=O)C |
Molecular Formula | C6H10O4 |
Wikipedia | ethylene glycol diacetate |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 146.142 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 5 |
Complexity | 114.0 |
CACTVS Substructure Key Fingerprint | A A A D c c B g O A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A G g A A A A A A A A C g g A I C C A A A B A A I A A C Q C A A A A A A A A A A A A A A A A A A B A A A A A A A C A A A A A A A C A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 52.6 |
Monoisotopic Mass | 146.058 |
Exact Mass | 146.058 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 10 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9705 |
Human Intestinal Absorption | HIA+ | 0.7492 |
Caco-2 Permeability | Caco2+ | 0.5645 |
P-glycoprotein Substrate | Non-substrate | 0.6875 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8668 |
Non-inhibitor | 0.8776 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.8651 |
Distribution | ||
Subcellular localization | Mitochondria | 0.8120 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8580 |
CYP450 2D6 Substrate | Non-substrate | 0.8952 |
CYP450 3A4 Substrate | Non-substrate | 0.6104 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8903 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8995 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9449 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9294 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9670 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9281 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9747 |
Non-inhibitor | 0.9387 | |
AMES Toxicity | AMES toxic | 0.6557 |
Carcinogens | Non-carcinogens | 0.6023 |
Fish Toxicity | High FHMT | 0.5825 |
Tetrahymena Pyriformis Toxicity | Low TPT | 0.6457 |
Honey Bee Toxicity | High HBT | 0.6646 |
Biodegradation | Ready biodegradable | 0.8378 |
Acute Oral Toxicity | IV | 0.6459 |
Carcinogenicity (Three-class) | Non-required | 0.6982 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -0.9374 | LogS |
Caco-2 Permeability | 0.6014 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 1.3605 | LD50, mol/kg |
Fish Toxicity | 0.8499 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | -0.8986 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Organic acids and derivatives |
Class | Carboxylic acids and derivatives |
Subclass | Dicarboxylic acids and derivatives |
Intermediate Tree Nodes | Not available |
Direct Parent | Dicarboxylic acids and derivatives |
Alternative Parents | |
Molecular Framework | Aliphatic acyclic compounds |
Substituents | Dicarboxylic acid or derivatives - Carboxylic acid ester - Organic oxygen compound - Organic oxide - Hydrocarbon derivative - Organooxygen compound - Carbonyl group - Aliphatic acyclic compound |
Description | This compound belongs to the class of organic compounds known as dicarboxylic acids and derivatives. These are organic compounds containing exactly two carboxylic acid groups. |
From ClassyFire